Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Bcl–2 protects from lethal hepatic apoptosis induced by an ant–Fas antibody in mice

Abstract

Fas is an apoptosis–signaling cell surface antigen that has been shown to trigger cell death upon specific ligand or antibody binding. Treatment of mice with an anti–Fas antibody causes fulminant hepatic failure due to massive apoptosis. To test a putative protective effect of the anti–apoptotic Bcl–2 protein, transgenic mice were generated to express the human bcl–2 gene product in hepatocytes. Early onset of massive hepatic apoptosis leading to death was observed in all nontransgenic mice treated with an anti–Fas antibody. By contrast, hepatic apoptosis was delayed and dramatically reduced in transgenic animals, yielding a 93% survival rate. These results demonstrate that Bcl–2 is able to protect from in vivoFas–mediated cytotoxicity, and could be of significance for preventing fulminant hepatic failure due to viral hepatitis in humans.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Thompson, C.B. Apoptosis in the pathogenesis and treatment of disease. Science 267, 1456–1462 (1995).

    Article  CAS  Google Scholar 

  2. Nagata, S. & Golstein, P., Fas death factor. Science 267, 1449–1456 (1995).

    Article  CAS  Google Scholar 

  3. Suda, T. & Nagata, S. Purification and characterization of the Fas-ligand that induces apoptosis. J. Exp. Med. 179, 873–879 (1994).

    Article  CAS  Google Scholar 

  4. Itoh, N. et al. The polypeptide encoded by the cDNA for the human cell surface antigen Fas can mediate apoptosis. Cell 66, 233–243 (1991).

    Article  CAS  Google Scholar 

  5. Trauth, B.C. et al. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245, 301–304 (1989).

    Article  CAS  Google Scholar 

  6. Rouvier, E., Luciani, M.F. & Golstein, P. Fas involvement in Ca2+-independent T cell-mediated cytotoxicity. J. Exp. Med. 177, 195–200 (1993).

    Article  CAS  Google Scholar 

  7. Kagi, D. et al. Fas and perform pathways as major mechanisms of T cell-mediated cytotoxiclty. Science 265, 528–530 (1994).

    Article  CAS  Google Scholar 

  8. Watanabe-Fukunaga, R., Brannan, C.I., Copeland, N.G., Jenkins, N.A. & Nagata, S. Lymphoproliferative disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356, 314–317 (1992).

    Article  CAS  Google Scholar 

  9. Takahashi, T. et al. Generalized lymphoproliferative disease in mice caused by a point mutation in the Fas ligand. Cell 76, 969–976 (1994).

    Article  CAS  Google Scholar 

  10. Rieux-Laucat, F. et al. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268, 1347–1349 (1995).

    Article  CAS  Google Scholar 

  11. Fisher, G.H. et al. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81, 935–946 (1995).

    Article  CAS  Google Scholar 

  12. Zornig, M., Grzeschiczek, A., Kowalski, M.B., Hartmann, K.U. & Moroy, T. Loss of Fas/APO-1 receptor accelerates lymphomagenesis in Em L-Myc transgenic mice but not in animals infected with MoMuLV. Oncogene 10, 2397–2401 (1995).

    CAS  PubMed  Google Scholar 

  13. Weller, M., Malipiero, U., Aguzzi, A., Reed, J.C. & Fontana, A., Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drags and therapeutic irradiation. J. Clin. Invest. 95, 2633–2643 (1995).

    Article  CAS  Google Scholar 

  14. Watanabe, D., Suda, T., Hashimoto, H. & Nagata, S. Constitutive activation of the Fas ligand gene in mouse lymphoproliferative disorders. EMBO J. 14, 12–18 (1995).

    Article  CAS  Google Scholar 

  15. Hiramatsu, N. et al. Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C. Hepatology 19, 1354–1359 (1994).

    Article  CAS  Google Scholar 

  16. Ogasawara, J. et al. Lethal effect of the anti-Fas antibody in mice. Nature 364, 806–809 (1993).

    Article  CAS  Google Scholar 

  17. Cleveland, J.L. & Ihle, J.N. Contenders in FasL/TNF death signalling. Cell 81, 479–482 (1995).

    Article  CAS  Google Scholar 

  18. Enari, M., Hug, H. & Nagata, S. Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 375, 78–81 (1995).

    Article  CAS  Google Scholar 

  19. Los, M. et al. Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis. Nature 375, 81–83 (1995).

    Article  CAS  Google Scholar 

  20. Korsmeyer, S.J. Regulators of cell death. Trends Genet. 11, 101–104 (1995).

    Article  CAS  Google Scholar 

  21. Itoh, N., Tsujimoto, Y. & Nagata, S. Effect of Bcl-2 on Fas antigen-mediated cell death. J. Immunol. 151, 621–627 (1993).

    CAS  PubMed  Google Scholar 

  22. Chiu, V.K., Walsh, C.M., Liu, C.C., Reed, J.C. & Clark, W.R. Bcl-2 blocks degranulation but not Fas-based cell-mediated cytotoxicity. J. Immunol. 154, 2023–2032 (1995).

    CAS  PubMed  Google Scholar 

  23. Vaux, D.L., Aguila, H.L. & Weissman, I.L. Bcl-2 prevents death of factor deprived cells but fails to prevent apoptosis in targets of cell-mediated killing. Int. Immunol. 4, 821–826 (1992).

    Article  CAS  Google Scholar 

  24. Tsujimoto, Y. & Croce, C.M. Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc. Natl. Acad. Sci. USA 83, 5214–5218 (1986).

    Article  CAS  Google Scholar 

  25. Miquerol, L. et al. Expression of the L-type pyruvate kinase gene and the hepatocyte nuclear factor 4 transcription factor in exocrine and endocrine pancreas. J. Biol. Chem. 269, 8944–8951 (1994).

    CAS  Google Scholar 

  26. Watanabe-Fukunaga, R. et al. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J. Immunol. 148, 1274–1279 (1992).

    CAS  Google Scholar 

  27. Tsujimoto, Y., Cossman, J., Jaffe, E. & Croce, C.M. Involvement of the bcl-2 gene in human follicular lymphoma. Science 228, 1440–1443 (1985).

    Article  CAS  Google Scholar 

  28. Reed, J.C. Bcl-2 and the regulation of programmed cell death. J. Cell. Biol. 124, 1–6 (1994).

    Article  CAS  Google Scholar 

  29. Zhao, M., Zhang, N.X., Economou, M., Laissue, J.A. & Zimmerman, A. Immunohistochemical detection of Bcl-2 protein in liver lesions: Bcl-2 protein is expressed in hepatocellular carcinomas but not in liver cell dysplasia. Histopathology 25, 237–245 (1994).

    Article  CAS  Google Scholar 

  30. Krajewski, S. et al. Immunohistochemical determination of in vivodistribution of Bax, a dominant inhibitor of Bcl-2. Am. J. Pathol. 145, 1323–1336 (1994).

    CAS  PubMed  PubMed Central  Google Scholar 

  31. Kiefer, M.C. et al. Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature 374, 736–739 (1995).

    Article  CAS  Google Scholar 

  32. Oltvai, Z.N. & Korsmeyer, S.J. Checkpoints of dueling dimers foil death wishes. Cell 79, 189–192 (1994).

    Article  CAS  Google Scholar 

  33. Oltvai, Z.N., Milliman, C.L. & Korsmeyer, S.J. Bcl-2 heterodimerizes in vivowith a conserved homolog, Bax, that accelerates programmed cell death. Cell 74, 609–619 (1993).

    Article  CAS  Google Scholar 

  34. Yang, E. et al. Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell 80, 285–291 (1995).

    Article  CAS  Google Scholar 

  35. Boise, L.H. et al. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74, 597–608 (1993).

    Article  CAS  Google Scholar 

  36. Mita, E. et al. Role of Fas ligand in apoptosis induced by hepatitis C virus infection. Biochem. Biophys. Res. Commun. 204, 468–474 (1994).

    Article  CAS  Google Scholar 

  37. Rehermann, B. et al. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. J. Exp. Med. 181, 1047–1058 (1995).

    Article  CAS  Google Scholar 

  38. Ando, K. et al. Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis. J. Exp. Med. 178, 1541–1554 (1993).

    Article  CAS  Google Scholar 

  39. Takahashi, H., Fujimoto, J., Hanada, S. & K J.Acute hepatitis in rats expressing human hepatitis B virus transgenes. Proc. Natl. Acad. Sci. USA 92, 1470–1474 (1995).

    Article  CAS  Google Scholar 

  40. Lacronique, V. et al. Identification and functional characterization of an erythroid-specific enhancer in the L-type pyruvate kinase gene. J. Biol. Chem. 270, 14989–14997 (1995).

    Article  CAS  Google Scholar 

  41. Chirgwin, J.M., Przybyla, A.E., MacDonald, R.J. & WJ.Isolation of biologically active ribonucleic acid from sources enriched in ribonucleases. Biochemistry 18, 5294–5299 (1979).

    Article  CAS  Google Scholar 

  42. Giannini, G. et al. The ryanodine receptor/calcium channel genes are widely and differentially expressed in murine brain and peripheral tissues. J. Cell Biol. 128, 893–904 (1995).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lacronique, V., Mignon, A., Fabre, M. et al. Bcl–2 protects from lethal hepatic apoptosis induced by an ant–Fas antibody in mice. Nat Med 2, 80–86 (1996). https://doi.org/10.1038/nm0196-80

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0196-80

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing